Kaplan–Meier analysis revealed worse recurrence‐free survival and cancer‐specific survival rates in DGKα‐positive patients compared to DGKα‐negative patients (p = 0.036 and = 0.003, respectively) (Figure 2C). The gene discussed is DGKA; the disease is cancer.